Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. - Wikidata - wikimedia - TriplyDB

Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.

Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.

http://www.wikidata.org/entity/Q39881351

about

Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters Dynamic vs static ABCG2 inhibitors to sensitize drug resistant cancer cells More than markers: biological significance of cancer stem cell-defining molecules.Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2.Sunitinib malate synergistically potentiates anti-tumor effect of gemcitabine in human bladder cancer cells.Two drug interaction studies of sirolimus in combination with sorafenib or sunitinib in patients with advanced malignancies.ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.Interaction of innovative small molecule drugs used for cancer therapy with drug transporters.PI3K/Akt inhibition and down-regulation of BCRP re-sensitize MCF7 breast cancer cell line to mitoxantrone chemotherapy.Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance.Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo.Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.Reversing multidrug resistance by tyrosine kinase inhibitors Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain.Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?Possibilities to increase the effectiveness of doxorubicin in cancer cells killing.Human ABCG2: structure, function, and its role in multidrug resistance.Resistance to antiangiogenic therapies.Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.Vaginal ecosystem modeling of growth patterns of anaerobic bacteria in microaerophilic conditions.ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer.Nilotinib enhances the efficacy of conventional chemotherapeutic drugs in CD34⁺CD38⁻ stem cells and ABC transporter overexpressing leukemia cells.Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.ABCG2/BCRP: Specific and Nonspecific Modulators.Sunitinib reverse multidrug resistance in gastric cancer cells by modulating Stat3 and inhibiting P-gp function.Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion.ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib.Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.Role of ABC transporters in cancer chemotherapy.

P2860

Q24617999-4A361280-8E11-4B8E-B184-F375E9849BF0 Q28476445-333787CE-7FC2-4918-A34B-A790DCD73FD2 Q33661278-36591CEA-A9AA-43AC-AAF3-FBE546AB8C0D Q33828409-F0FABFF8-B40A-40BB-9894-E0E9B581EC0C Q34046157-3AF81312-2442-439F-A6CE-FB1FF3BF1615 Q34253081-9819BEE5-3650-4ED3-A8FE-9172487A2164 Q34567910-E3A4C348-44BC-491E-9F00-3799827442DE Q34795914-83CA5974-2972-4457-94FE-2DCF9FDC7E91 Q35171274-C0BC99DB-3238-43AD-9D94-766A56B5FF5C Q35708124-6E7115B5-C33F-422F-96F7-1E2946FE556B Q35763457-24682BE9-82DB-4D41-A9CD-20FC9554CB1E Q35946822-F8182B89-598E-4876-8575-B11C7AC567C8 Q36021057-C8041452-0B20-475B-820E-D98D08AA41EC Q36057369-8EDE82EC-1DEE-41CE-B1D3-432AEDFCB772 Q36166672-B882D510-4624-4B8F-9253-EF744AFB89EE Q36212765-DBEE1C9E-084D-4776-86CA-153414501E4A Q36282183-0894A12E-5F81-4CFD-820D-9AD2020D6A7B Q36308299-92F2FB30-C4B4-40F2-AFDC-EF29EB452EA4 Q36442931-A3FE7F85-9F53-4302-AF1B-5BAE714A918E Q36689070-AFFFF85A-EF4F-40D2-820A-E2FAE8ED481B Q37183670-56831315-3D3E-4E27-8365-555A206BF3B8 Q37331814-0E106507-72C0-47C7-B883-B0B90679825D Q37333659-48277554-F569-49F7-A656-D39460923EE0 Q37739472-B7C99A42-58C5-4712-A404-C3C6F4BBF23D Q37853578-9A64B7F1-77F0-4456-ABFF-2FF355AC0253 Q37937579-A3E4CF67-C03A-43E1-AE9E-71047DB129D5 Q38003156-7E818BCD-EE2C-4F4B-A858-30221B48EC7B Q38232852-66BB07D5-A767-46BA-92F8-15ECA7114F83 Q38246305-35BCAC67-F32C-4B37-9E3A-A8D86DA08A34 Q38812851-6BD1686E-BBC7-437F-A84B-0BE616FA90DC Q38848383-4A24A93B-2CA0-43D1-840C-9A927248EC60 Q39013427-EE8FE8FC-ACA9-4EDE-9A06-1CEFAE766563 Q39015818-C96571DB-622D-4B28-AF46-40B761139289 Q39049159-5350C074-91F2-44BA-93CC-547046813B79 Q39183426-AAA4D20E-AD00-406D-8F7C-2A339F9818CB Q39594943-BFC8B521-0DE9-44AB-A73D-8E166EC419C1 Q40852245-FF437137-53FE-435B-970E-965A8F4CF29E Q41813347-7667BEC7-6D06-4A8B-B59F-248A887201AC Q41872813-BFE076CD-2A29-4601-A190-6B682D647553 Q42637698-993A899E-F73C-4E99-A00D-3839ACD9F5AD

P2860

Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.

http://www.wikidata.org/entity/Q39881351

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Sensitization of ABCG2-overexp ...... ibiting the function of ABCG2.

@en

Sensitization of ABCG2-overexp ...... ibiting the function of ABCG2.

@nl

type

label

Sensitization of ABCG2-overexp ...... ibiting the function of ABCG2.

@en

Sensitization of ABCG2-overexp ...... ibiting the function of ABCG2.

@nl

prefLabel

Sensitization of ABCG2-overexp ...... ibiting the function of ABCG2.

@en

Sensitization of ABCG2-overexp ...... ibiting the function of ABCG2.

@nl

P1433

Q39881351-160F6B6D-3502-41D7-91B4-4BD3AD509968

P1476

Q39881351-1B0A5D98-10F3-4B3A-9C1F-45F4546B7660

P2093

Q39881351-87BB97A4-7745-44BB-8097-9941DDD81402

Q39881351-87D158DD-378E-4FE5-B51C-D3D53CB00F94

Q39881351-894E9074-CBDF-4A53-85ED-70066BD03B2F

Q39881351-8C4226FD-EF92-4172-AFC8-B8E6FDEF1B5D

Q39881351-99881EE2-53EB-421A-8EDD-11D19796DCFD

Q39881351-9CF8B971-8139-48F4-BD80-32D2EE9E6834

Q39881351-C7C6472D-4A70-4E04-A5C3-C26BC9CDA6DB

Q39881351-CB7B11FF-71CD-45F6-B9FA-56C1BA3F9DAB

Q39881351-EDD5DB39-4AD2-4877-87CB-137251254C51

Q39881351-FF2D4559-C62C-4A40-AE97-B3946D4328B7

P304

Q39881351-1A98466B-9B8E-4C9E-80EA-9AF9802B42CF

P31

Q39881351-2506ECB2-8B62-47DB-8C0F-D82E35D9CB67

P356

Q39881351-062361F5-51DB-4DDC-9E87-BC6014B571BF

P407

Q39881351-D460AA84-011B-46FB-A3CF-F1A435B1EE93

P433

Q39881351-0DBC8903-3738-4EC3-BD5E-146E1526A29B

P478

Q39881351-2E14F5C1-A5C0-4AC4-B5C7-24F1DE6F7258

P577

Q39881351-DD10629D-95E5-49FE-8ABA-2678459671C6

P698

Q39881351-5EF9D25B-91E8-4BD3-8B9B-E9BEC7D20443

P921

Q39881351-69D75581-DC7B-4B78-A70F-26806A594185

Q39881351-7209B354-605F-43EA-9E21-1590A9281EA3

P356

J.CANLET.2009.01.027

P1433

P1476

Sensitization of ABCG2-overexp ...... ibiting the function of ABCG2.

@en

P2093

Amit K Tiwari

http://www.w3.org/2001/XMLSchema#string

Chun-ling Dai

http://www.w3.org/2001/XMLSchema#string

Fang Wang

http://www.w3.org/2001/XMLSchema#string

Li-wu Fu

http://www.w3.org/2001/XMLSchema#string

Xiu-zhen Tong

http://www.w3.org/2001/XMLSchema#string

Yan-sheng Wang

http://www.w3.org/2001/XMLSchema#string

Yan-yan Yan

http://www.w3.org/2001/XMLSchema#string

Yong-ju Liang

http://www.w3.org/2001/XMLSchema#string

Zhe-sheng Chen

http://www.w3.org/2001/XMLSchema#string

P304

74-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CANLET.2009.01.027

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19232821

http://www.w3.org/2001/XMLSchema#string

P921